Exanthema clinical trials

The registry lists 68 studies for Exanthema across more than 10 countries. 11 are recruiting or about to start. 29 of them are mainly about Exanthema (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.

Get an email when these change. Save the Exanthema studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 33
Terminated: 10
Status unknown: 8
Recruiting: 8
Withdrawn: 5
Not yet recruiting: 2

Phase

Phase 2: 23
Phase 3: 8
Phase 1: 5
Phase 4: 4

Where

United States: 24
France: 6
Canada: 4
Netherlands: 3
United Kingdom: 3
Italy: 3

Who runs them

Northwestern University (4) · Hospices Civils de Lyon (2) · Memorial Sloan Kettering Cancer Center (2) · Amgen (2) · Merz North America, Inc. (2) · Novartis Pharmaceuticals (2) · Universidad de Granada (1) · OrchestratePharma GmbH (1)

What is being tested here

Drugs under test in Exanthema studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Deucravacitinib	1	1	1
Prednisone	0	1	2
Dupilumab	0	0	1
Tetracycline	0	0	1
Chlorhexidine gluconate	0	0	1
Chlorhexidine	0	0	1
Carisbamate	0	0	1
Erlotinib	0	0	1
Dapsone	0	1	1
Canakinumab	0	0	1

Drug classes tested here Corticosteroids 3

Coming up

1phase 3 study under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Jan 2027Cardamom and Topical Roseomonas in Atopic Dermatitis · National Institute of Allergy and Infectious Diseases (NIAID)
Apr 2027Rash & Diarrhea Prophylaxis With Capivasertib · Maryam Lustberg
May 2027Wucao Anfu Formula as Adjunctive Treatment for Immune Checkpoint Inhibitor-Related Rash · First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Jul 2027A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity · Azitra Inc.

Who these studies take

Of the 8 Exanthema studies recruiting now, 3 (38%) set no upper age limit and 3 (38%) stop at 75 or younger. 4 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (25%) take healthy volunteers.

Recruiting studies that take each age, of 8
Age	Women	Men
10	1 (13%)	1 (13%)
18	5 (63%)	5 (63%)
30	5 (63%)	5 (63%)
40	5 (63%)	5 (63%)
50	5 (63%)	5 (63%)
65	5 (63%)	5 (63%)
75	5 (63%)	5 (63%)
85	4 (50%)	4 (50%)

Across all 68 studies, recruiting or not: 32% stop at 75 or younger and 28% at 65; 43% take children; 3% are for women only and 1% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 68. Browse all 68 → or search them.